BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1462424)

  • 1. [Regression of hypertensive cardiovascular changes during treatment with antihypertensive ddrugs].
    Schroeder AP; Pedersen OL
    Ugeskr Laeger; 1992 Nov; 154(46):3230-6. PubMed ID: 1462424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and the cardiovascular system.
    Dzau VJ
    J Hypertens Suppl; 1992 Jun; 10(3):S3-10. PubMed ID: 1386105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
    Novo S; Abrignani MG; Corda M; Strano A
    Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACE-inhibitors and cardiovascular protection].
    Agabiti-Rosei E; Muiesan ML
    Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of biochemical changes in heart muscle hypertrophy].
    Zähringer J
    Z Kardiol; 1985; 74 Suppl 7():119-26. PubMed ID: 2868582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibition: mechanisms of cardioprotection in heart hypertrophy].
    Motz W; Strauer BE
    Klin Wochenschr; 1991; 69 Suppl 24():39-43; discussion 43-4. PubMed ID: 1830911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trandolapril in patients with essential hypertension: effects on vascular and cardiac structural changes.
    Rendina V; Iaccarino G; Russo R; Enea J; Marchegiano R; Lembo G; Trimarco B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S20-4. PubMed ID: 7519692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cardiovascular structural changes during long-term antihypertensive therapy.
    Agabiti-Rosei E; Muiesan ML
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():41-7. PubMed ID: 1834845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic problems in hypertensive heart disease].
    Strauer BE
    Z Kardiol; 1993; 82 Suppl 4():17-24. PubMed ID: 8147058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heart (ventricle and atrium) is the heart of hypertension, not blood pressure.
    Gubner RS
    Can J Cardiol; 1990 Oct; 6(8):367-72. PubMed ID: 2148501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.